Patents by Inventor Gila Maor

Gila Maor has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9657080
    Abstract: The invention relates to peptides useful for inhibiting IGF-1 activity and their use as agents for inhibition of in vitro cell proliferation and for treatment of various diseases.
    Type: Grant
    Filed: January 30, 2015
    Date of Patent: May 23, 2017
    Assignee: Universite Pierre Et Marie Curie (Paris 6)
    Inventors: Claude Carelli, Zvi Laron, Gila Maor
  • Publication number: 20150133380
    Abstract: The invention relates to peptides useful for inhibiting IGF-1 activity and their use as agents for inhibition of in vitro cell proliferation and for treatment of various diseases.
    Type: Application
    Filed: January 30, 2015
    Publication date: May 14, 2015
    Inventors: Claude Carelli, Zvi Laron, Gila Maor
  • Patent number: 8975225
    Abstract: The invention relates to peptides useful for inhibiting IGF-1 activity and their use as agents for inhibition of in vitrocell proliferation and for treatment of various diseases.
    Type: Grant
    Filed: March 19, 2009
    Date of Patent: March 10, 2015
    Assignee: Universite Pierre et Marie Curie (Paris 6)
    Inventors: Claude Carelli, Zvi Laron, Gila Maor
  • Patent number: 8802815
    Abstract: The invention relates to peptides for modulate IGF-1 activity, a pharmaceutical composition comprising them as well as their applications as medicinal products and cell proliferation modulating agents in vitro.
    Type: Grant
    Filed: March 18, 2010
    Date of Patent: August 12, 2014
    Assignee: Universite Pierre et Marie Curie (Paris 6)
    Inventors: Claude Carelli, Zvi Laron, Gila Maor
  • Publication number: 20120149640
    Abstract: The invention relates to peptides for modulate IGF-1 activity, a pharmaceutical composition comprising them as well as their applications as medicinal products and cell proliferation modulating agents in vitro.
    Type: Application
    Filed: March 18, 2010
    Publication date: June 14, 2012
    Inventors: Claude Carelli, Zvi Laron, Gila Maor
  • Publication number: 20120135926
    Abstract: The invention relates to peptides useful for inhibiting IGF-1 activity and their use as agents for inhibition of in vitrocell proliferation and for treatment of various diseases.
    Type: Application
    Filed: March 19, 2009
    Publication date: May 31, 2012
    Applicant: UNIVERSITE PIERRE ET MARIE CURIE (PARIS 6)
    Inventors: Claude Carelli, Zvi Laron, Gila Maor
  • Publication number: 20100209397
    Abstract: The present invention relates in general to the field of tissue engineering, and in particular to methods for repair and regeneration of diseased and injured bone and cartilage tissue by allotransplantation or xenotransplantation of neonatal mandibular condyle-derived chondrocytes. The composition may comprise mandibular condyle-derived chondrocytes in the form of a chondrocyte film, per se, or in combination with a scaffold.
    Type: Application
    Filed: November 12, 2006
    Publication date: August 19, 2010
    Applicant: CARTICURE LTD.
    Inventor: Gila Maor
  • Publication number: 20100135967
    Abstract: A method of generating cultured chondrocytes/endochondral bone cells is provided. The method comprising isolating chondrocytes from mandibular condyle tissue, and culturing the isolated chondrocytes. A method of isolating chondrocytes from mandibular condyle tissue is further provided. The method comprises isolating mandibular condyle tissue from a mammal and treating the mandibular condyle tissue so as to selectively remove fibroblast-like cells and/or myocytes therefrom, the modified mandibular condyle tissue including chondrocytes, and selectively collecting the chondrocytes from the modified mandibular condyle tissue.
    Type: Application
    Filed: December 7, 2009
    Publication date: June 3, 2010
    Applicant: Technion Research & Development Foundation Ltd.
    Inventor: Gila Maor
  • Patent number: 7642092
    Abstract: A method of generating cultured chondrocytes/endochondral bone cells is provided. The method comprising isolating chondrocytes from mandibular condyle tissue, and culturing the isolated chondrocytes. A method of isolating chondrocytes from mandibular condyle tissue is further provided. The method comprises isolating mandibular condyle tissue from a mammal and treating the mandibular condyle tissue so as to selectively remove fibroblast-like cells and/or myocytes therefrom, the modified mandibular condyle tissue including chondrocytes, and selectively collecting the chondrocytes from the modified mandibular condyle tissue.
    Type: Grant
    Filed: July 28, 2003
    Date of Patent: January 5, 2010
    Assignee: Technion Research & Development Foundation Ltd.
    Inventor: Gila Maor
  • Publication number: 20040247589
    Abstract: The invention discloses anti-tumor activity in the sera of certain reptiles, more particularly in the serum of alligators or crocodiles. The active principle resides in one or more serum proteins or polypeptides that inhibit the growth of mammalian tumor cells in culture while being practically devoid of such inhibitory activity toward normal cells in culture. The active fractions obtained from the sera show no overt toxicity in healthy mammals, and this novel anti-tumor agent may therefore be used for the prevention, investigation, treatment or diagnosis of neoplasms.
    Type: Application
    Filed: January 20, 2004
    Publication date: December 9, 2004
    Inventors: Ofer Binah, Aaron Ciechanover, Gila Maor
  • Publication number: 20040191901
    Abstract: The present invention discloses insulin producing cells derived from human embryonic stem cells. Methods of generating, enriching, selecting, cloning and isolating populations of insulin-producing embryonic cell lines are disclosed. Insulin production in these cells can be glucose responsive or otherwise regulatable. Advantageously, these insulin producing cells can be stable cell lines derived from stable transfectants of hESC. Methods of using these cells, cell populations or cell lines particularly for cell replacement therapy are also disclosed.
    Type: Application
    Filed: November 14, 2003
    Publication date: September 30, 2004
    Inventors: Suheir Assady, Gila Maor, Michal Amit, Joseph Itskovitz-Eldor, Karl L. Skorecki, Maty Tzukerman
  • Publication number: 20040175826
    Abstract: A method of generating cultured chondrocytes/endochondral bone cells is disclosed. The method comprises isolating chondrocytes from mandibular condyle tissue, and culturing said isolated chondrocytes.
    Type: Application
    Filed: July 28, 2003
    Publication date: September 9, 2004
    Applicant: Technion Research & Development Foundation Ltd.
    Inventor: Gila Maor